PTGS2 and neoplasm: Recently, Markosyan and co-workers identified the ephrin-A receptor 2/TGF-β/SMAD/PTGS2 axis as a key tumor-intrinsic driver of immunosuppressive TME in spontaneous PDAC mouse model [113].